860692P

C16:0 Ceramide (d18:2(4E,8Z)/16:0)

Avanti Research^™ - A Croda Brand 860692P, powder

• 别名: N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base)
• 经验公式（希尔记法）: C₃₄H₆₅NO₃
• CAS号: 1919028-96-8
• 分子量: 535.88
• 分類程式碼代碼: 12352211
• NACRES: NA.25

属性

• 形狀: powder
• 包裝: pkg of 1 × 1 mg (860692P-1mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 860692P
• 脂質類型: sphingolipids
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: OC[C@@](NC(CCCCCCCCCCCCCCC)=O)([H])[C@]([H])(O)/C=C/CC/C=C\CCCCCCCCC
• InChI: 1S/C34H65NO3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33(37)32(31-36)35-34(38)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h19,21,27,29,32-33,36-37H,3-18,20,22-26,28,30-31H2,1-2H3,(H,35,38)/b21-19-,29-27+/t32-,33+/m0/s1
• InChI 密鑰: GMWIWVUTMCBDSP-JXXPSAROSA-N

说明

一般說明

C16:0 Ceramide (d18:2(4E,8Z)/16:0) or N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base) is a long chain ceramide derived from sphingosine containing two double bonds with palmitic acid. C16:0 Ceramide synthesis is catalyzed by the enzyme ceramide synthase 6 (CerS6).

生化／生理作用

C16:0-ceramide facilitates obesity-related insulin resistance. It exhibits pro-apoptotic function. Elevated levels of C16:0-ceramide has been observed in adipose tissue of obese patients.

包裝

5 mL Amber Glass Screw Cap Vial (860692P-1mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全信息

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: No data available
• 閃點（°C）: No data available